Skip to content

Craniosacral Therapy to Treat Chronic Low Back Pain

Effectiveness of a Craniosacral Therapy Program on Disability, Quality of Life, Autonomic Nervous System and Oxidative Stress Indicators in Chronic Low Back Pain: a Randomized Controlled Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01822236
Enrollment
70
Registered
2013-04-02
Start date
2013-04-30
Completion date
2013-12-31
Last updated
2015-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Back Pain

Keywords

low back pain, Manual Therapy, Randomized Controlled Trial, Quality of life

Brief summary

The purpose of this study is to determine whether a craniosacral therapy program are effective on disability, quality of life, autonomic nervous system and oxidative stress indicators in patients with chronic low back pain.

Detailed description

Design: Randomized clinical trial. Objective: to determine the effectiveness of a craniosacral therapy program on disability, quality of life, autonomic nervous system, body mass, hormonal indicators, spinal projection, and oxidative stress indicators in patients with chronic low back pain. Participants: Seventy patients with chronic non-specific low back pain will be randomly assigned to an experimental and control group. Intervention: For 10-week, the experimental group will undergo treatment comprising 10 sessions (1/week) of a craniosacral therapy program with ten techniques, and the control group will receive only one craniosacral technique. Main Outcome Measures: disability, quality of life, biochemical estimation interstitial fluid, body mass indicators, hormonal indicators, indicators of autonomic nervous system,and indicators of oxidative stress will be collected in both groups at baseline, 10 weeks and 15 weeks after the last intervention in the experimental and control groups, by an assessor blinded to the treatment allocation of the patients. Baseline demographic and clinical variables will be examined between both groups with an independent Student t-test for continuous data. Separate 2x3 model ANOVA with time (baseline, 10 weeks and 15 weeks) as the within-subjects factor, group (experimental, control) will be to determine the effects of the treatment.

Interventions

OTHERCraniosacral Therapy Program

The ten techniques of craniosacral therapy program are: Still Point (CV-4, Sacred Feet), diaphragms(pelvic, respiratory, thoracic inlet, hyoid, Occipital Cranial Base), Decompression L5-S1, Dural Tube Glide, Lift Front, Parietal Lift, Compression / decompression of the joint sphenobasilar, Temporary Technique, Compression / decompression of the temporomandibular joints, and Still Point CV-4.

OTHEROne technique of craniosacral therapy

Decompression L5-S1: lumbosacral decompression

Sponsors

Universidad de Granada
CollaboratorOTHER
Universidad de Almeria
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
25 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Low back pain for \> 3 months * Score \> 4 on the Roland Morris Disability questionnaire * No undergoing another physical therapy treatment

Exclusion criteria

* Clinical signs of radiculopathy * Presence of lumbar stenosis * Fibromyalgia * Spondylolisthesis * History of spinal surgery * Treatment with corticosteroids in the past two weeks * Disease of the central or peripheral nervous system

Design outcomes

Primary

MeasureTime frameDescription
Change for the Roland Morris Disability QuestionnaireAt baseline, 10 weeks and 15 weeksThe Roland Morris Disability Questionnaire is a self-administered disability measurement scored on a 24-point scale from 0 = no disability to 24 = severe disability

Secondary

MeasureTime frameDescription
Change for the Lifestyle indicatorsAt baseline, 10 weeks and 15 weeksEstimation interstitial fluid biochemistry and measure the following indicators: body mass, hormonal, autonomic nervous system and oxidative stress.
Change on Neural Network AnalysisAt baseline, 10 weeks and 15 weeksAnalysis of the projection on the spine and segmental innervation projection
Change on Quality of LifeAt baseline, 10 weeks and 15 weeksSF-36 Health questionnaire scores range from 0 to 100% and indicate the self-perceived health-related quality of life

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026